This course has expired. View available courses.
Neurology
Migraine prevention in general practice – ACRRM
An estimated 4.9 million Australians experience migraine causing significant pain, suffering and loss of wellbeing. Globally, migraine is the sixth highest cause of disability, and the third highest for people aged <50 years. Preventive treatments play an important role in the management of migraine for a proportion of those affected. The new CGRP inhibitor class was specifically developed for the treatment of migraine and overcomes many limitations of previous preventive therapies, thereby providing an opportunity for GPs to improve outcomes in patients with migraine.
This 1-hour accredited activity aims to empower GPs to diagnose and adopt best practice management of migraines to improve quality of life and functional outcomes for patients. It features two cases studies and expert video interviews from the faculty.
This program is supported by an independent educational grant provided by Eli Lilly.
DURATION
1 hr
PROFESSION
Physician
# OF CREDITS
1
ACCREDITATION
ACRRM
EXPIRY DATE
2022-12-31
An estimated 4.9 million Australians experience migraine causing significant pain, suffering and loss of wellbeing. Globally, migraine is the sixth highest cause of disability, and the third highest for people aged <50 years. Preventive treatments play an important role in the management of migraine for a proportion of those affected. The new CGRP inhibitor class was specifically developed for the treatment of migraine and overcomes many limitations of previous preventive therapies, thereby providing an opportunity for GPs to improve outcomes in patients with migraine.
This 1-hour accredited activity aims to empower GPs to diagnose and adopt best practice management of migraines to improve quality of life and functional outcomes for patients. It features two cases studies and expert video interviews from the faculty.
This program is supported by an independent educational grant provided by Eli Lilly.
Faculty
A/Prof Richard Stark,
AM, MB, BS, FRACP Neurologist
Simon Cowap, GP
Learning objectives
On completion of this program, GPs will be better able to:
- Define migraine as a neurological disorder and understand its clinical phases
- Recognise the burden of migraine including its significant impact on quality of life
- Demonstrate how the introduction of CGRP inhibitors has changed the treatment paradigm in migraine prevention
- Identify patients who could benefit from timely introduction of preventive therapy, including CGRP inhibitors
- Confidently initiate preventative treatments as an effective strategy in migraine management
- Develop strategies for ensuring optimal outcomes with preventive therapy including monitoring, counseling patients on administration and adherence, and providing self-care advice
Accreditation
This PDP Activity is accredited by The Australian College of Rural & Remote Medicine for 1 hour of Educational Activity.
Activity no. 25009